Skip to main content

Medicine

Latest Medicine stories from Life.

Life

Discovery of Key Enzyme in Bioluminescent Fungi Could Revolutionize Medical Tools

Researchers have identified a crucial enzyme in bioluminescent fungi, potentially leading to more effective medical tools that utilize light.

Life

Exploring Goat's Rue: The Plant Behind a Revolutionary Diabetes Medication

Goat’s rue, a wild plant known for its beauty, has played a significant role in the development of metformin, a key medication for diabetes and obesity, without the adverse effects.

Life

23andMe Teams Up with HealthEx to Integrate DNA Data and Medical Records

At the STAT Breakthrough Summit West, 23andMe announced a partnership with HealthEx, enabling users to connect their DNA data with their medical records.

Life

Virginia Governor Blocks Initiative to Reduce Prescription Drug Costs

In a notable decision, Virginia's governor has vetoed legislation that sought to establish an advisory panel aimed at lowering prescription drug prices, impacting potential savings for residents.

Life

Breakthrough in Drug Development: New Molecules from Sea Sponge Bacteria

Researchers at Florida State University have made significant strides in drug discovery by synthesizing new molecules from bacteria sourced from a Pacific Ocean sea sponge, which could aid in developing treatments for rare cancers.

Life

Study Reveals Gaps in Conflict-of-Interest Policies Among Canadian Medical Societies

A recent analysis indicates that most Canadian medical societies do not have adequate conflict-of-interest policies, with many existing policies being fragmented and limited in scope.

Life

Maryland Sets Price Cap on Ozempic Amid National Drug Affordability Efforts

In a notable move, Maryland's State Affordability Board has established a price cap on Ozempic, joining nine other states exploring similar affordability measures for prescription drugs.

Life

TrumpRx Expands with Help from Amazon, GoodRx, and Mark Cuban

The Trump administration has announced a significant expansion of its drug discount platform, TrumpRx, adding 600 generic medications through partnerships with major online pharmacies.

Life

Innovative Microneedle Patch Vaccine Aims to Transform Agricultural Practices

Researchers at the University of Connecticut have developed a microneedle patch vaccine that could address significant challenges in agricultural vaccine distribution.

Life

Experts Consider Testing Unapproved Ebola Vaccine Amid Outbreak in DRC

As the Ebola outbreak continues in the Democratic Republic of the Congo, experts are contemplating the testing of an unapproved vaccine, given the lack of approved options.

Life

AstraZeneca Secures FDA Approval for New Hypertension Treatment

AstraZeneca has received FDA approval for its hypertension medication, marking a significant development in the biotech sector amid ongoing discussions about FDA leadership and other industry news.

Life

Supreme Court Dismisses Challenge to Medicare Drug Price Negotiation

The Supreme Court's decision could complicate ongoing lawsuits from pharmaceutical companies regarding drug price negotiations.

Life

U.K. Advocacy Groups Consider Legal Action Against Pharma Trade Agreement

Two advocacy groups are urging the U.K. government to reconsider regulations tied to a U.S. pharma trade deal, threatening legal action if changes are not made.

Life

Concerns Grow as FDA Drug Center Head Tracy Beth Høeg Resigns

Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.

Life

Understanding Federal Vaccine Injury Compensation Programs: Key Insights

This editorial explores the federal government's Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program, highlighting their history and ongoing policy discussions.

Life

U.S. Urges Germany to Reconsider Drug Pricing Strategies Amid Ongoing FDA Changes

In the latest Pharmalittle update, the U.S. is applying pressure on Germany regarding drug pricing policies, alongside notable changes within the FDA and developments in biotech clinical trials.

Life

Justice Department Raises Concerns Over Admissions Practices at Yale and UCLA Medical Schools

The DOJ has accused Yale and UCLA medical schools of potentially discriminatory admissions practices against white and Asian applicants, highlighting ongoing debates about equity in education.

Life

BeOne Secures FDA Approval in Lymphoma Treatment

In a significant development, BeOne has received FDA approval for its lymphoma treatment. Meanwhile, Regenxbio is making strides in Duchenne gene therapy, among other biotech updates.

Life

Pharmalittle: Highlights from Recent Developments in Medicine

Biogen has shared mixed findings from a mid-stage trial for an Alzheimer’s treatment aimed at the tau protein, amidst other industry news.

Life

Decline in U.S. Overdose Deaths in 2025 Raises Concerns Over Future Policies

Preliminary government data indicates a 14% decrease in drug overdose deaths in 2025, with around 70,000 fatalities reported. However, experts express concern over potential policy and drug supply changes.